Correlation Between Mineralys Therapeutics, and Arrowhead Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on Mineralys Therapeutics, and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Arrowhead Pharmaceuticals.
Diversification Opportunities for Mineralys Therapeutics, and Arrowhead Pharmaceuticals
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and Arrowhead is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Arrowhead Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Arrowhead Pharmaceuticals
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 1.07 times more return on investment than Arrowhead Pharmaceuticals. However, Mineralys Therapeutics, is 1.07 times more volatile than Arrowhead Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 1,600 in Mineralys Therapeutics, Common on August 28, 2024 and sell it today you would lose (330.00) from holding Mineralys Therapeutics, Common or give up 20.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 91.31% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Arrowhead Pharmaceuticals
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Arrowhead Pharmaceuticals |
Mineralys Therapeutics, and Arrowhead Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Arrowhead Pharmaceuticals
The main advantage of trading using opposite Mineralys Therapeutics, and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |